 |
January 2012
Comprehensive Study
Drug Market Exclusivity in the EU and Canada:
Problems with Norton Rose’s Comparative Analysis |
|
October 11, 2011
Comprehensive Study
Potential Impact on the Generic
Pharmaceutical Industry in Canada |
|
June 23, 2011
Comprehensive Study
The Real Story Behind Big Pharma's RD Spending in Canada, 2011 |
|
May 30, 2011
Comprehensive Study
Canada's Intellectual Property Protection for Pharmaceuticals Stronger In May Ways than EU and US
|
|
February 7, 2011
Comprehensive Study
The Canada-European Union Comprehensive Economic & Trade Agreement: An Economic Impact Assessment of Proposed Pharmaceutical Intellectual Property Provisions |
|
June 24, 2010
Comprehensive Study
The Real Story Behind Big Pharma's RD Spending in Canada, 2010 |
|
August 12, 2009
Comprehensive Study
The Real Story Behind R&D Spending by Brand-Name Drug Companies in Canada |
|
December 1, 2008
Comprehensive Study
Response to the Fraser Institute's Report - Canada's Drug Price Paradox 2008 |
|
September 17, 2008
Submission to the Government of Canada
Anti-Counterfeiting Trade Agreement |
|
July 2008
Comprehensive Study
The Real Story Behind Big Pharma’s
R&D Spending in Canada |
|
May 13, 2008
Submission to the Standing Committee on Health
Review of the 10-Year Plan to Strengthen Health Care |
|
April 16, 2008
Submission to the Standing Committee on Industry, Science and Technology
Study on Science and Technology |
|
September 2007
Comprehensive Study
The Real Story Behind Big Pharma's R&D Spending in Canada |
|
Novemember 2005
Comprehensive Study
Comparisons of Retail Prices of Generic Prescription Drugs in Canada vs. United States |
|
December 2004
Comprehensive Study
Patently Absurd: Evergreening of Pharmaceutical Patents under the Patented Medicines (Notice of Compliance) Regulations of Canada’s Patent Act |
|
February 2004
Submission to House of Commons Standing Committee on Industry, Science and Technology
Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act |
|
February 2004
Submission to Quebec’s Standing Committee on Finance and Economic Affairs
Three Proposals for $70 Million in Annual Health Care Savings |
|
November 2003
Submission to House of Commons Standing Committee on Health
Generic Drug Makers at a Crossroads: The Path to Health-Care Savings and the Sustainability of Canada’s Generic Pharmaceutical Industry |
|
June 2003
Submission to House of Commons Standing Committee on Industry, Science and Technology
Patented Medicines (Notice of Compliance) Regulations |
|
| |
|
TOP |
| |
|
|
